Grant name: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
Funding organization: National Institutes of Health (NIH), National Cancer Institute (NCI)
Total funding amount: $1,000,000
Duration: Maximum project period of 3 years
Primary objective: To support the development of innovative technologies for biospecimen handling in cancer research
Significance: Aims to enhance research in cancer biology, early detection, and treatment
Grant frequency: One-time funding opportunity
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City or Township Governments
Indian/Native American Tribal Governments (both recognized and non-recognized)
Federal Government Agencies
Foreign Organizations
Organizations must complete registrations with SAM, eRA Commons, and Grants.gov prior to application submission.
Development of innovative technologies for biospecimen collection, handling, processing, preservation, and storage.
Addressing cancer health disparities and improving the quality of biospecimens for research.
Technologies should enhance research capabilities and address unmet needs in cancer research.
Applicants must demonstrate the capability to develop innovative biospecimen technologies.
Maximum budget per application: $150,000 per year
Total project budget may not exceed $450,000 over 3 years.
Application due date: October 3, 2025
Earliest start date: April 4, 2025
All applications must comply with NIH Grants Policy Statement.
Applications must be submitted electronically through Grants.gov.
A letter of intent is encouraged but not required.